Kovitz Investment Group Partners’s CVS Health CVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$19.5M Buy
270,972
+222,781
+462% +$17.2M 0.45% 57
2025
Q4
$3.82M Sell
48,191
-214,172
-82% -$16.9M 0.08% 160
2025
Q3
$19.8M Buy
262,363
+56,476
+27% +$3.87M 0.08% 216
2025
Q2
$14.2M Buy
205,887
+1,372
+0.7% +$90K 0.06% 246
2025
Q1
$13.9M Buy
204,515
+7,302
+4% +$437K 0.07% 219
2024
Q4
$8.85M Sell
197,213
-17,063
-8% -$957K 0.04% 293
2024
Q3
$12.6M Buy
214,276
+13,117
+7% +$765K 0.09% 190
2024
Q2
$11.9M Buy
201,159
+60,191
+43% +$3.77M 0.1% 145
2024
Q1
$11.2M Buy
140,968
+8,644
+7% +$660K 0.14% 98
2023
Q4
$10.4M Sell
132,324
-7,042
-5% -$501K 0.17% 61
2023
Q3
$9.73M Buy
139,366
+22,578
+19% +$1.6M 0.17% 61
2023
Q2
$8.07M Buy
116,788
+2,902
+3% +$206K 0.12% 89
2023
Q1
$8.46M Buy
113,886
+2,805
+3% +$235K 0.15% 86
2022
Q4
$10.4M Sell
111,081
-1,220
-1% -$118K 0.2% 70
2022
Q3
$10.7M Sell
112,301
-40
-0% -$3.96K 0.25% 58
2022
Q2
$10.4M Buy
112,341
+50
+0% +$4.88K 0.23% 65
2022
Q1
$11.4M Sell
112,291
-20,874
-16% -$2.19M 0.22% 69
2021
Q4
$9.1M Buy
133,165
+19,381
+17% +$1.79M 0.21% 71
2021
Q3
$9.66M Sell
113,784
-741
-0.6% -$62.1K 0.19% 75
2021
Q2
$9.56M Sell
114,525
-19,031
-14% -$1.56M 0.19% 81
2021
Q1
$10M Buy
133,556
+391
+0.3% +$28.5K 0.23% 70
2020
Q4
$9.1M Buy
133,165
+13,565
+11% +$882K 0.22% 69
2020
Q3
$6.99M Sell
119,600
-38,676
-24% -$2.41M 0.2% 83
2020
Q2
$10.3M Buy
158,276
+1,620
+1% +$102K 0.32% 53
2020
Q1
$9.29M Buy
156,656
+6,839
+5% +$457K 0.34% 52
2019
Q4
$11.1M Buy
149,817
+136
+0.1% +$9.55K 0.32% 50
2019
Q3
$9.45M Sell
149,681
-4,034
-3% -$239K 0.3% 57
2019
Q2
$8.38M Buy
153,715
+15,454
+11% +$832K 0.26% 63
2019
Q1
$7.46M Buy
138,261
+56,982
+70% +$3.52M 0.24% 68
2018
Q4
$5.33M Buy
81,279
+76,762
+1,699% +$5.73M 0.21% 79
2018
Q3
$356K Sell
4,517
-13
-0.3% -$929 0.02% 124
2018
Q2
$292K Buy
+4,530
New +$299K 0.01% 129
2017
Q3
Sell
-2,492
Closed -$201K 157
2017
Q2
$201K Sell
2,492
-823
-25% -$65K 0.01% 151
2017
Q1
$260K Sell
3,315
-715,902
-100% -$57.2M 0.01% 119
2016
Q4
$56.8M Buy
719,217
+227,394
+46% +$18.4M 3.31% 11
2016
Q3
$43.8M Buy
491,823
+147,677
+43% +$13.9M 2.69% 13
2016
Q2
$30.8M Sell
344,146
-17,163
-5% -$1.71M 2.14% 21
2016
Q1
$37.5M Buy
+361,309
New +$35.1M 2.21% 20

Other funds holding CVS

Kovitz Investment Group Partners's CVS Position: Q1 2026 in Review

Kovitz Investment Group Partners increased its CVS Health (CVS) stake by 462% in Q1 2026, buying an estimated $17.2M and bringing the position to 270,972 shares worth $19.5M. The position accounts for 0.45% of the portfolio, ranked #57.

Kovitz Investment Group Partners first reported a position in CVS in Q1 2016 and has held it in 38 quarters since. The position peaked at $56.8M in Q4 2016. 1,873 funds tracked by Wall St. Rank hold CVS as of Q1 2026.

  • Kovitz Investment Group Partners held 270,972 shares of CVS Health worth $19.5M as of Q1 2026.
  • Kovitz Investment Group Partners bought 222,781 CVS Health shares in Q1 2026, an estimated $17.2M.
  • CVS Health made up 0.45% of Kovitz Investment Group Partners's portfolio in Q1 2026, its #57 holding.
  • Kovitz Investment Group Partners first reported a position in CVS Health in Q1 2016 and has held it in 38 quarters since.
  • Kovitz Investment Group Partners's CVS Health position peaked at $56.8M in Q4 2016.
  • 1,873 funds tracked by Wall St. Rank held CVS Health as of Q1 2026.

Based on Kovitz Investment Group Partners's 13F filing for Q1 2026, filed 13 May 2026.